Obstetric antiphospholipid syndrome: An update on pathophysiology and management

Seminars in Reproductive Medicine

Volumn 29, Issue 6, 2011, Pages 522-539

  Ernest, Joseph M ^a   Marshburn, Paul B ^a   Kutteh, William H ^b  

^a CAROLINAS MEDICAL CENTER   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

antiphospholipid antibodies; Antiphospholipid syndrome; complications of pregnancy; fetal demise; obstetric antiphospholipid syndrome; recurrent pregnancy loss; thrombosis; unfractionated heparin

Indexed keywords

ACETYLSALICYLIC ACID; BETA2 GLYCOPROTEIN 1; CALCIUM; CARDIOLIPIN; ENOXAPARIN; FONDAPARINUX; HEPARIN; HIRUDIN; KAOLIN; LOW MOLECULAR WEIGHT HEPARIN; LUPUS ANTICOAGULANT; ORAL CONTRACEPTIVE AGENT; PHOSPHOLIPID ANTIBODY; PREDNISONE; THROMBOPLASTIN; TUMOR NECROSIS FACTOR ALPHA; VITAMIN D;

ANTIPHOSPHOLIPID SYNDROME; ARTICLE; BLEEDING; DRUG MEGADOSE; DRUG SAFETY; ENZYME LINKED IMMUNOSORBENT ASSAY; FETUS DEATH; GESTATIONAL AGE; HISTOPATHOLOGY; HUMAN; INTRAUTERINE GROWTH RETARDATION; LOW DRUG DOSE; MATERNAL HYPERTENSION; OSTEOPENIA; PARTIAL THROMBOPLASTIN TIME; PLACENTA INSUFFICIENCY; PREECLAMPSIA; PREGNANCY COMPLICATION; PREGNANCY DIABETES MELLITUS; PREGNANCY OUTCOME; PREGNANCY TEST; PREMATURE LABOR; PUERPERIUM; RECURRENT ABORTION; SINGLE DRUG DOSE; STILLBIRTH; SYNCYTIOTROPHOBLAST; THROMBOCYTE COUNT; THROMBOCYTOPENIA; THROMBOSIS; TREATMENT RESPONSE; TROPHOBLAST;

ABORTION, HABITUAL; ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; ASPIRIN; FEMALE; HEPARIN; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; PLACENTAL INSUFFICIENCY; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS; THROMBOSIS;

EID: 83455162249     PISSN: 15268004     EISSN: 15264564     Source Type: Journal    
DOI: 10.1055/s-0031-1293206     Document Type: Article

References (148)

1. De Wolf F, Carreras L O., Moerman P, Vermylen J, Van Assche A, Renaer M. Decidual vasculopathy and extensive placental infarction in a patient with repeated thromboembolic accidents, recurrent fetal loss, and a lupus anticoagulant. Am J Obstet Gynecol 1982 142 7 829-834 (Pubitemid 12142941)
2. Adler R R., Ng A K., Rote N S. Monoclonal antiphosphatidylserine antibody inhibits intercellular fusion of the choriocarcinoma line, JAR. Biol Reprod 1995 53 4 905-910
3. Katsuragawa H, Kanzaki H, Inoue T, Hirano T, Mori T, Rote N S. Monoclonal antibody against phosphatidylserine inhibits in vitro human trophoblastic hormone production and invasion. Biol Reprod 1997 56 1 50-58 (Pubitemid 27024161)
4. Quenby S, Mountfield S, Cartwright J E., Whitley G S., Chamley L, Vince G. Antiphospholipid antibodies prevent extravillous trophoblast differentiation. Fertil Steril 2005 83 3 691-698 (Pubitemid 40348582)
5. Rand J H. Molecular pathogenesis of the antiphospholipid syndrome. Circ Res 2002 90 1 29-37 (Pubitemid 34074605)
6. Out H J., Kooijman C D., Bruinse H W., Derksen R H. Histopathological findings in placentae from patients with intra-uterine fetal death and anti-phospholipid antibodies. Eur J Obstet Gynecol Reprod Biol 1991 41 3 179-186
7. Kutteh W H., Rote N S., Silver R. Antiphospholipid antibodies and reproduction: the antiphospholipid antibody syndrome. Am J Reprod Immunol 1999 41 2 133-152 (Pubitemid 29110262)
8. Schust D J., Hill J A. Recurrent Pregnancy Loss. Philadelphia, PA Lippincott Williams & Wilkins 2002
9. Rand J H. The antiphospholipid syndrome. Annu Rev Med 2003 54 409-424 (Pubitemid 37386404)
10. Harris E N., Gharavi A E., Boey M L. et al. Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet 1983 2 8361 1211-1214 (Pubitemid 14229783)
11. Wasserman A, Neisser A, Bruck C. Eine Serodiagnostiche reaktion bei syphilis. Dtsch Med Wochenschr 1906 32 745-749
12. Landsteiner K, Muller R, Potzl D. Studies on the complement binding reaction in syphilis. Wien Klin Wochenschr 1907 20 1565
13. Pangborn M C., Pangborn M C. A new seriologically active phospholipid from beef heart. Proc Soc Exp Biol Med 1941 48 484-486
14. Moore J E., Mohr C F. Biologically false positive serologic tests for syphilis; type, incidence, and cause. J Am Med Assoc 1952 150 5 467-473
15. Conley C L., Hartmann R C. A hemorrhagic disorder caused by circulating anticoagulant in patients with disseminated lupus erythematosus. J Lab Clin Invest 1952 31 621-622
16. Beaumont J L. Acquired hemorrhagic syndrome caused by a circulating anticoagulant; inhibition of the thromboplastic function of the blood platelets; description of a specific test. [in French]. Sang 1954 25 1-5
17. Laurell A B., Nilsson I M. Hypergammaglobulinemia, circulating anticoagulant, and biologic false positive Wassermann reaction; a study in two cases. J Lab Clin Med 1957 49 5 694-707
18. Bowie E J., Thompson J H. Jr, Pascuzzi C A., Owen C A. Jr. Thrombosis in systemic lupus erythematosus despite circulating anticoagulants. J Lab Clin Med 1963 62 416-430
19. Alarcon Segovia D, Osmundson P J. Peripheral vascular syndromes associated with systemic lupus erythematosus. Ann Intern Med 1965 62 907-919
20. Lechner K. A new type of coagulation inhibitor. Thromb Diath Haemorrh 1969 21 3 482-499
21. Feinstein D I., Rapaport S I. Acquired inhibitors of blood coagulation. Prog Hemost Thromb 1972 1 75-95
22. Nilsson I M., Astedt B, Hedner U, Berezin D. Intrauterine death and circulating anticoagulant (antithromboplastin). Acta Med Scand 1975 197 3 153-159
23. Von Felton A, Gehrig D, Martius F. Antiphospholipid antibodies as a cause of thrombocytopenia and p-pathia. Eur J Clin Invest 1977 7 223
24. Soulier J P., Boffa M C. Avortements à répétition, thromboses et anticoagulant circulant anti-thromboplastine. Nouv Presse Med 1980 9 859-864
25. Thiagarajan P, Shapiro S S., De Marco L. Monoclonal immunoglobulin M lambda coagulation inhibitor with phospholipid specificity. Mechanism of a lupus anticoagulant. J Clin Invest 1980 66 3 397-405 (Pubitemid 10053902)
26. Carreras L O., Vermylen J, Spitz B, Van Assche A. Lupus anticoagulant and inhibition of prostacyclin formation in patients with repeated abortion, intrauterine growth retardation and intrauterine death. Br J Obstet Gynaecol 1981 88 9 890-894 (Pubitemid 11018180)
27. Hughes G RV. Thrombosis, abortion, cerebral disease, and the lupus anticoagulant. Br Med J (Clin Res Ed) 1983 287 6399 1088-1089 (Pubitemid 13011933)
28. Hughes G RV. The anticardiolipin syndrome. Clin Exp Rheumatol 1985 3 4 285-286 (Pubitemid 16209618)
29. Loizou S, McCrea J D., Rudge A C., Reynolds R, Boyle C C., Harris E N. Measurement of anti-cardiolipin antibodies by an enzyme-linked immunosorbent assay (ELISA): standardization and quantitation of results. Clin Exp Immunol 1985 62 3 738-745 (Pubitemid 16250493)
30. Harris E N., Baguley E, Asherson R A., Hughes G RV. Clinical and serological features of the antiphospholipid syndrome (APS). Br J Rheumatol 1987 26 Suppl 2 19
31. Branch D W., Rote N S., Dostal D A., Scott J R. Association of lupus anticoagulant with antibody against phosphatidylserine. Clin Immunol Immunopathol 1987 42 1 63-75 (Pubitemid 17231584)
32. McNeil H P., Simpson R J., Chesterman C N., Krilis S A. Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H). Proc Natl Acad Sci U S A 1990 87 11 4120-4124
33. Rosove M H., Tabsh K, Wasserstrum N, Howard P, Hahn B H., Kalunian K C. Heparin therapy for pregnant women with lupus anticoagulant or anticardiolipin antibodies. Obstet Gynecol 1990 75 4 630-634 (Pubitemid 20110181)
34. Kutteh W H. Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone. Am J Obstet Gynecol 1996 174 5 1584-1589 (Pubitemid 26165282)
35. Wilson W A., Gharavi A E., Koike T et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 1999 42 7 1309-1311 (Pubitemid 30265586)
36. Lockshin M D. Antiphospholipid antibody. Babies, blood clots, biology. JAMA 1997 277 19 1549-1551 (Pubitemid 27213305)
37. Alarcón-Segovia D, Delezé M, Oria C V. et al. Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus. A prospective analysis of 500 consecutive patients. Medicine (Baltimore) 1989 68 6 353-365 (Pubitemid 19286655)
38. Kutteh W H., Lyda E C., Abraham S M., Wacholtz M C. Association of anticardiolipin antibodies and pregnancy loss in women with systemic lupus erythematosus. Fertil Steril 1993 60 3 449-455 (Pubitemid 23278800)
39. Miyakis S, Lockshin M D., Atsumi T et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006 4 2 295-306
40. Harris E N. Syndrome of the black swan. Br J Rheumatol 1987 26 5 324-326
41. American College of Obstetricians and Gynecologists Committee on Practice Bulletins-Obstetrics. ACOG Practice Bulletin No. 118: Antiphospholipid syndrome. Obstet Gynecol 2011 117 1 192-199
42. Silver R M., Draper M L., Scott J R., Lyon J L., Reading J, Branch D W. Clinical consequences of antiphospholipid antibodies: an historic cohort study. Obstet Gynecol 1994 83 3 372-377 (Pubitemid 24067805)
43. Martin B A., Branch D W., Rodgers G M. Sensitivity of the activated partial thromboplastin time, the dilute Russell's viper venom time, and the kaolin clotting time for the detection of the lupus anticoagulant: a direct comparison using plasma dilutions. Blood Coagul Fibrinolysis 1996 7 1 31-38
44. Pengo V, Tripodi A, Reber G et al, Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis. Update of the guidelines for lupus anticoagulant detection. J Thromb Haemost 2009 7 10 1737-1740
45. Di Simone N, Meroni P L., de Papa N et al. Antiphospholipid antibodies affect trophoblast gonadotropin secretion and invasiveness by binding directly and through adhered beta2-glycoprotein I. Arthritis Rheum 2000 43 1 140-150 (Pubitemid 30368223)
46. McIntyre J A. Immune recognition at the maternal-fetal interface: overview. Am J Reprod Immunol 1992 28 34 127-131 (Pubitemid 23044812)
47. Schousboe I, Rasmussen M S. Synchronized inhibition of the phospholipid mediated autoactivation of factor XII in plasma by beta 2-glycoprotein I and anti-beta 2-glycoprotein I. Thromb Haemost 1995 73 5 798-804
48. Gleicher N, el-Roeiy A, Confino E, Friberg J. Reproductive failure because of autoantibodies: unexplained infertility and pregnancy wastage. Am J Obstet Gynecol 1989 160 6 1376-1380; discussion 13801385
49. Matzner W, Chong P, Xu G, Ching W. Characterization of antiphospholipid antibodies in women with recurrent spontaneous abortions. J Reprod Med 1994 39 1 27-30 (Pubitemid 24048370)
50. Gilman-Sachs A, Lubinski J, Beer A E., Brend S, Beaman K D. Patterns of anti-phospholipid antibody specificities. J Clin Lab Immunol 1991 35 2 83-88
51. Branch D W., Silver R, Pierangeli S S., van Leeuwen I, Harris E N. Antiphospholipid antibodies other than lupus anticoagulant and anticardiolipin antibodies in women with recurrent pregnancy loss, fertile controls, and antiphospholipid syndrome. Obstet Gynecol 1997 89 4 549-555 (Pubitemid 27133528)
52. Yetman D L., Kutteh W H. Antiphospholipid antibody panels and recurrent pregnancy loss: prevalence of anticardiolipin antibodies compared with other antiphospholipid antibodies. Fertil Steril 1996 66 4 540-546 (Pubitemid 26315154)
53. Kutteh W H., Corey A, Jaslow C R. Antiphospholipid antibodies and recurrent pregnancy loss: Prevalence of anticardiolipin antibodies, the lupus anticoagulant, and antiphosphatidyl serine antibodies. Lupus 2010 19 546
54. Peaceman A M., Silver R M., MacGregor S N., Socol M L. Interlaboratory variation in antiphospholipid antibody testing. Am J Obstet Gynecol 1992 166 1780-1784
55. Carreras L O., Forastiero R R., Martinuzzo M E. Which are the best biological markers of the antiphospholipid syndrome? J Autoimmun 2000 15 2 163-172
56. Kutteh W H., Franklin R D. Assessing the variation in antiphospholipid antibody (APA) assays: comparison of results from 10 centers. Am J Obstet Gynecol 2004 191 2 440-448 (Pubitemid 39178696)
57. Franklin R D., Kutteh W H. Effects of unfractionated and low molecular weight heparin on antiphospholipid antibody binding in vitro. Obstet Gynecol 2003 101 3 455-462 (Pubitemid 36288484)
58. Franklin R D., Kutteh W H. Antiphospholipid antibodies (APA) and recurrent pregnancy loss: treating a unique APA positive population. Hum Reprod 2002 17 11 2981-2985 (Pubitemid 35350923)
59. Eby C. Antiphospholipid syndrome review. Clin Lab Med 2009 29 2 305-319
60. Rodger M A. Thrombophilia and placenta-mediated pregnancy complications: from the bench to bedside to policy. Thromb Res 2009 123 Suppl 2 S100-S104
61. Benedetto C, Marozio L, Tavella A M., Salton L, Grivon S, Di Giampaolo F. Coagulation disorders in pregnancy: acquired and inherited thrombophilias. Ann N Y Acad Sci 2010 1205 106-117
62. Hatasaka H H. Recurrent miscarriage: epidemiologic factors, definitions, and incidence. Clin Obstet Gynecol 1994 37 3 625-634 (Pubitemid 24323541)
63. Branch D W., Carson S A. The American College of Obstetricians and Gynecologists. Management of Recurrent Early Pregnancy Loss. Washington, DC The American College of Obstetricians and Gynecologists 2001. ACOG Practice Bulletin No. 24
64. Jaslow C R., Carney J L., Kutteh W H. Diagnostic factors identified in 1020 women with two versus three or more recurrent pregnancy losses. Fertil Steril 2010 93 4 1234-1243
65. Allison J L., Schust D J. Recurrent first trimester pregnancy loss: revised definitions and novel causes. Curr Opin Endocrinol Diabetes Obes 2009 16 6 446-450
66. Vinatier D, Dufour P, Cosson M, Houpeau J L. Antiphospholipid syndrome and recurrent miscarriages. Eur J Obstet Gynecol Reprod Biol 2001 96 1 37-50 (Pubitemid 32331848)
67. Chauleur C, Galanaud J P., Alonso S et al. Observational study of pregnant women with a previous spontaneous abortion before the 10th gestation week with and without antiphospholipid antibodies. J Thromb Haemost 2010 8 4 699-706
68. Vora S, Shetty S, Ghosh K. Thrombophilic dimension of recurrent fetal loss in Indian patients. Blood Coagul Fibrinolysis 2008 19 6 581-584
69. Oron G, Ben-Haroush A, Goldfarb R, Molad Y, Hod M, Bar J. Contribution of the addition of anti-2-glycoprotein to the classification of antiphospholipid syndrome in predicting adverse pregnancy outcome. J Matern Fetal Neonatal Med 2011 24 4 606-609
70. Abrahams V M. Mechanisms of antiphospholipid antibody-associated pregnancy complications. Thromb Res 2009 124 5 521-525
71. Ziakas P D., Pavlou M, Voulgarelis M. Heparin treatment in antiphospholipid syndrome with recurrent pregnancy loss: a systematic review and meta-analysis. Obstet Gynecol 2010 115 6 1256-1262
72. Hoppe B, Burmester G R., Dörner T. Heparin or aspirin or both in the treatment of recurrent abortions in women with antiphospholipid antibody (syndrome). Curr Opin Rheumatol 2011 23 3 299-304
73. Backos M, Rai R, Baxter N, Chilcott I T., Cohen H, Regan L. Pregnancy complications in women with recurrent miscarriage associated with antiphospholipid antibodies treated with low dose aspirin and heparin. Br J Obstet Gynaecol 1999 106 2 102-107 (Pubitemid 29065223)
74. Branch D W., Khamashta M A. Antiphospholipid syndrome: obstetric diagnosis, management, and controversies. Obstet Gynecol 2003 101 6 1333-1344 (Pubitemid 36694363)
75. Robertson L, Wu O, Langhorne P et al, Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) Study. Thrombophilia in pregnancy: a systematic review. Br J Haematol 2006 132 2 171-196 (Pubitemid 43381552)
76. Alfirevic Z, Roberts D, Martlew V. How strong is the association between maternal thrombophilia and adverse pregnancy outcome? A systematic review. Eur J Obstet Gynecol Reprod Biol 2002 101 1 6-14 (Pubitemid 34142238)
77. Ruffatti A, Tonello M, Cavazzana A, Bagatella P, Pengo V. Laboratory classification categories and pregnancy outcome in patients with primary antiphospholipid syndrome prescribed antithrombotic therapy. Thromb Res 2009 123 3 482-487
78. Werner E F., Lockwood C J. Thrombophilias and stillbirth. Clin Obstet Gynecol 2010 53 3 617-627
79. Nodler J, Moolamalla S R., Ledger E M., Nuwayhid B S., Mulla Z D. Elevated antiphospholipid antibody titers and adverse pregnancy outcomes: analysis of a population-based hospital dataset. BMC Pregnancy Childbirth 2009 9 11-18
80. do Prado A, Piovesan D, Staub H, Horta B L. Association of anticardiolipin antibodies with pre-eclampsia: a systematic review and meta-analysis. Obstet Gynecol 2010 116 1433-1443
81. Heilmann L, Schorsch M, Hahn T, Fareed J. Antiphospholipid syndrome and pre-eclampsia. Semin Thromb Hemost 2011 37 2 141-145
82. Branch D W., Silver R M., Blackwell J L., Reading J C., Scott J R. Outcome of treated pregnancies in women with antiphospholipid syndrome: an update of the Utah experience. Obstet Gynecol 1992 80 4 614-620
83. Cowchock F S., Reece E A., Balaban D, Branch D W., Plouffe L. Repeated fetal losses associated with antiphospholipid antibodies: a collaborative randomized trial comparing prednisone with low-dose heparin treatment. Am J Obstet Gynecol 1992 166 5 1318-1323
84. Laskin C A., Bombardier C, Hannah M E. et al. Prednisone and aspirin in women with autoantibodies and unexplained recurrent fetal loss. N Engl J Med 1997 337 3 148-153 (Pubitemid 27306285)
85. Kutteh W H., Ermel L D. A clinical trial for the treatment of antiphospholipid antibody-associated recurrent pregnancy loss with lower dose heparin and aspirin. Am J Reprod Immunol 1996 35 4 402-407 (Pubitemid 26131087)
86. Empson M, Lassere M, Craig J C., Scott J R. Recurrent pregnancy loss with antiphospholipid antibody: a systematic review of therapeutic trials. Obstet Gynecol 2002 99 1 135-144 (Pubitemid 34075480)
87. Lima F, Khamashta M A., Buchanan N M., Kerslake S, Hunt B J., Hughes G R. A study of sixty pregnancies in patients with the antiphospholipid syndrome. Clin Exp Rheumatol 1996 14 2 131-136 (Pubitemid 26156755)
88. Yasuda M, Takakuwa K, Tokunaga A, Tanaka K. Prospective studies of the association between anticardiolipin antibody and outcome of pregnancy. Obstet Gynecol 1995 86 4 Pt 1 555-559
89. Motta M, Lachassinne E, Boffa M C. et al. European registry of infants born to mothers with antiphospholipid syndrome: preliminary results. Minerva Pediatr 2010 62 3, Suppl 1 25-27
90. Levine J S., Branch D W., Rauch J. The antiphospholipid syndrome. N Engl J Med 2002 346 10 752-763 (Pubitemid 34983997)
91. Tincani A, Balestrieri G, Danieli E et al. Pregnancy complications of the antiphospholipid syndrome. Autoimmunity 2003 36 1 27-32 (Pubitemid 36321905)
92. Meroni P L., Riboldi P. Pathogenic mechanisms mediating antiphospholipid syndrome. Curr Opin Rheumatol 2001 13 5 377-382 (Pubitemid 32929866)
93. Branch D W., Dudley D J., Mitchell M D. et al. Immunoglobulin G fractions from patients with antiphospholipid antibodies cause fetal death in BALB/c mice: a model for autoimmune fetal loss. Am J Obstet Gynecol 1990 163 1 Pt 1 210-216 (Pubitemid 20253090)
94. Blank M, Cohen J, Toder V, Shoenfeld Y. Induction of antiphospholipid syndrome in naive mice with mouse lupus monoclonal and human polyclonal anti-cardiolipin antibodies. Proc Natl Acad Sci U S A 2001 88 3069-3073
95. Piona A, La Rosa L, Tincani A et al. Placental thrombosis and fetal loss after passive transfer of mouse lupus monoclonal or human polyclonal anti-cardiolipin antibodies in pregnant naive BALB/c mice. Scand J Immunol 1995 41 5 427-432
96. Ornoy A, Yacobi S, Matalon S T. et al. The effects of antiphospholipid antibodies obtained from women with SLE/APS and associated pregnancy loss on rat embryos and placental explants in culture. Lupus 2003 12 7 573-578 (Pubitemid 36890154)
97. Hanly J G., Gladman D D., Rose T H., Laskin C A., Urowitz M B. Lupus pregnancy. A prospective study of placental changes. Arthritis Rheum 1988 31 3 358-366 (Pubitemid 18091658)
98. Nayar R, Lage J M. Placental changes in a first trimester missed abortion in maternal systemic lupus erythematosus with antiphospholipid syndrome; a case report and review of the literature. Hum Pathol 1996 27 2 201-206 (Pubitemid 26049477)
99. Turiel M, Sarzi-Puttini P, Peretti R et al. Thrombotic risk factors in primary antiphospholipid syndrome: a 5-year prospective study. Stroke 2005 36 7 1490-1494 (Pubitemid 40967518)
100. Gharavi A E., Pierangeli S S., Espinola R G., Liu X, Colden-Stanfield M, Harris E N. Antiphospholipid antibodies induced in mice by immunization with a cytomegalovirus-derived peptide cause thrombosis and activation of endothelial cells in vivo. Arthritis Rheum 2002 46 2 545-552 (Pubitemid 34136593)
101. Galli M, Luciani D, Bertolini G, Barbui T. Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature. Blood 2003 101 5 1827-1832 (Pubitemid 36237580)
102. Peaceman A M., Rehnberg K A. The effect of immunoglobulin G fractions from patients with lupus anticoagulant on placental prostacyclin and thromboxane production. Am J Obstet Gynecol 1993 169 6 1403-1406 (Pubitemid 24009168)
103. Cariou R, Tobelem G, Soria C, Caen J. Inhibition of protein C activation by endothelial cells in the presence of lupus anticoagulant. N Engl J Med 1986 314 18 1193-1194 (Pubitemid 16138675)
104. Cosgriff T M., Martin B A. Low functional and high antigenic antithrombin III level in a patient with the lupus anticoagulant and recurrent thrombosis. Arthritis Rheum 1981 24 1 94-96 (Pubitemid 11163047)
105. Vogt E, Ng A K., Rote N S. A model for the antiphospholipid antibody syndrome: monoclonal antiphosphatidylserine antibody induces intrauterine growth restriction in mice. Am J Obstet Gynecol 1996 174 2 700-707 (Pubitemid 26070168)
106. Robertson S A., Roberts C T., van Beijering E et al. Effect of beta2-glycoprotein I null mutation on reproductive outcome and antiphospholipid antibody-mediated pregnancy pathology in mice. Mol Hum Reprod 2004 10 6 409-416 (Pubitemid 38714373)
107. Yasuda S, Tsutsumi A, Chiba H et al. beta(2)-glycoprotein I deficiency: prevalence, genetic background and effects on plasma lipoprotein metabolism and hemostasis. Atherosclerosis 2000 152 2 337-346
108. Rand J H., Wu X X., Quinn A S., Taatjes D J. The annexin A5-mediated pathogenic mechanism in the antiphospholipid syndrome: role in pregnancy losses and thrombosis. Lupus 2010 19 4 460-469
109. Rand J H., Wu X X., Andree H A. et al. Pregnancy loss in the antiphospholipid-antibody syndromea possible thrombogenic mechanism. N Engl J Med 1997 337 3 154-160 (Pubitemid 27306286)
110. Out H J., Bruinse H W., Christiaens G C. et al. A prospective, controlled multicenter study on the obstetric risks of pregnant women with antiphospholipid antibodies. Am J Obstet Gynecol 1992 167 1 26-32
111. Salafia C M., Cowchock F S. Placental pathology and antiphospholipid antibodies: a descriptive study. Am J Perinatol 1997 14 8 435-441 (Pubitemid 27400996)
112. Greaves M, Cohen H, MacHin S J., Mackie I. Guidelines on the investigation and management of the antiphospholipid syndrome. Br J Haematol 2000 109 4 704-715 (Pubitemid 30609746)
113. Sebire N J., Fox H, Backos M, Rai R, Paterson C, Regan L. Defective endovascular trophoblast invasion in primary antiphospholipid antibody syndrome-associated early pregnancy failure. Hum Reprod 2002 17 4 1067-1071 (Pubitemid 34411147)
114. Di Simone N, Caliandro D, Castellani R, Ferrazzani S, De Carolis S, Caruso A. Low-molecular weight heparin restores in-vitro trophoblast invasiveness and differentiation in presence of immunoglobulin G fractions obtained from patients with antiphospholipid syndrome. Hum Reprod 1999 14 2 489-495 (Pubitemid 29097408)
115. Sthoeger Z M., Mozes E, Tartakovsky B. Anti-cardiolipin antibodies induce pregnancy failure by impairing embryonic implantation. Proc Natl Acad Sci U S A 1993 90 14 6464-6467 (Pubitemid 23207233)
116. Di Simone N, Castellani R, Caliandro D, Caruso A. Antiphospholid antibodies regulate the expression of trophoblast cell adhesion molecules. Fertil Steril 2002 77 4 805-811 (Pubitemid 34275366)
117. Tedesco F, Narchi G, Radillo O, Meri S, Ferrone S, Betterle C. Susceptibility of human trophoblast to killing by human complement and the role of the complement regulatory proteins. J Immunol 1993 151 3 1562-1570 (Pubitemid 23219294)
118. Holers V M., Girardi G, Mo L et al. Complement C3 activation is required for antiphospholipid antibody-induced fetal loss. J Exp Med 2002 195 2 211-220 (Pubitemid 34461265)
119. Girardi G, Berman J, Redecha P et al. Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome. J Clin Invest 2003 112 11 1644-1654 (Pubitemid 38063722)
120. Salmon J E., Girardi G. The role of complement in the antiphospholipid syndrome. Curr Dir Autoimmun 2004 7 133-148
121. Berman J, Girardi G, Salmon J E. TNF-alpha is a critical effector and a target for therapy in antiphospholipid antibody-induced pregnancy loss. J Immunol 2005 174 1 485-490 (Pubitemid 40007438)
122. Blank M, Krause I, Wildbaum G, Karin N, Shoenfeld Y. TNFalpha DNA vaccination prevents clinical manifestations of experimental antiphospholipid syndrome. Lupus 2003 12 7 546-549 (Pubitemid 36890148)
123. Boles J, Mackman N. Role of tissue factor in thrombosis in antiphospholipid antibody syndrome. Lupus 2010 19 4 370-378
124. Alijotas-Reig J, Vilardell-Tarres M. Is obstetric antiphospholipid syndrome a primary nonthrombotic, proinflammatory, complement-mediated disorder related to antiphospholipid antibodies? Obstet Gynecol Surv 2010 65 1 39-45
125. Stone S, Pijnenborg R, Vercruysse L et al. The placental bed in pregnancies complicated by primary antiphospholipid syndrome. Placenta 2006 27 45 457-467
126. Cavazzana I, Manuela N, Irene C et al. Complement activation in anti-phospholipid syndrome: a clue for an inflammatory process? J Autoimmun 2007 28 23 160-164 (Pubitemid 46680500)
127. Girardi G, Redecha P, Salmon J E. Heparin prevents antiphospholipid antibody-induced fetal loss by inhibiting complement activation. Nat Med 2004 10 11 1222-1226 (Pubitemid 39540439)
128. Di Simone N, Castellani R, Raschi E, Borghi M O., Meroni P L., Caruso A. Anti - 2 glycoprotein I antibodies affect Bcl-2 and Bax trophoblast expression without evidence of apoptosis. Ann N Y Acad Sci 2006 1069 364-376 (Pubitemid 43989879)
129. Di Simone N, Di Nicuolo F, Sanguinetti M et al. Low-molecular weight heparin induces in vitro trophoblast invasiveness: role of matrix metalloproteinases and tissue inhibitors. Placenta 2007 28 4 298-304 (Pubitemid 46505937)
130. Ermel L D., Marshburn P B., Kutteh W H. Interaction of heparin with antiphospholipid antibodies (APA) from the sera of women with recurrent pregnancy loss (RPL). Am J Reprod Immunol 1995 33 1 14-20
131. Stephenson M D., Houlihan E, Tsang P, Ensworth S, Lim K, Ballem P J. Concomitant use of IVIG for treatment of the antiphospholipid antibody syndrome (APS) when ASA and heparin results in at least one adverse pregnancy outcome. Lupus 2002 11 694
132. Nelson-Piercy C, Letsky E A., de Swiet M. Low-molecular-weight heparin for obstetric thromboprophylaxis: experience of sixty-nine pregnancies in sixty-one women at high risk. Am J Obstet Gynecol 1997 176 5 1062-1068 (Pubitemid 27227520)
133. Brenner B, Hoffman R, Blumenfeld Z, Weiner Z, Younis J S. Gestational outcome in thrombophilic women with recurrent pregnancy loss treated by enoxaparin. Thromb Haemost 2000 83 5 693-697 (Pubitemid 30248516)
134. Farquharson R G., Quenby S, Greaves M. Antiphospholipid syndrome in pregnancy: a randomized, controlled trial of treatment. Obstet Gynecol 2002 100 3 408-413 (Pubitemid 35246124)
135. Stephenson M D., Ballem P J., Tsang P et al. Treatment of antiphospholipid antibody syndrome (APS) in pregnancy: a randomized pilot trial comparing low molecular weight heparin to unfractionated heparin. J Obstet Gynaecol Can 2004 26 8 729-734
136. Noble L S., Kutteh W H., Lashey N, Franklin R D., Herrada J. Antiphospholipid antibodies associated with recurrent pregnancy loss: prospective, multicenter, controlled pilot study comparing treatment with low-molecular-weight heparin versus unfractionated heparin. Fertil Steril 2005 83 3 684-690 (Pubitemid 40348581)
137. Erkan D, Merrill J T., Yazici Y, Sammaritano L, Buyon J P., Lockshin M D. High thrombosis rate after fetal loss in antiphospholipid syndrome: effective prophylaxis with aspirin. Arthritis Rheum 2001 44 6 1466-1467 (Pubitemid 32537548)
138. Sher G, Feinman M, Zouves C et al. High fecundity rates following in-vitro fertilization and embryo transfer in antiphospholipid antibody seropositive women treated with heparin and aspirin. Hum Reprod 1994 9 2278-2283
139. Balasch J, Creus M, Fábregues F et al. Antiphospholipid antibodies and human reproductive failure. Hum Reprod 1996 11 10 2310-2315 (Pubitemid 26392031)
140. Geva E, Amit A, Lerner-Geva L, Lessing J B. Autoimmunity and reproduction. Fertil Steril 1997 67 4 599-611 (Pubitemid 27152363)
141. Hornstein M D. Antiphospholipid antibodies in patients undergoing IVF: the data do not support testing. Fertil Steril 2000 74 4 635-636
142. Silver R M., Draper M L., Scott J R., Lyon J L., Reading J, Branch D W. Clinical consequences of antiphospholipid antibodies: an historic cohort study. Obstet Gynecol 1994 83 3 372-377 (Pubitemid 24067805)
143. Rai R, Cohen H, Dave M, Regan L. Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies). BMJ 1997 314 7076 253-257 (Pubitemid 27047378)
144. Branch D W., Peaceman A M., Druzin M et al, The Pregnancy Loss Study Group. A multicenter, placebo-controlled pilot study of intravenous immune globulin treatment of antiphospholipid syndrome during pregnancy. Am J Obstet Gynecol 2000 182 1 Pt 1 122-127 (Pubitemid 30074379)
145. Pattison N S., Chamley L W., Birdsall M, Zanderigo A M., Liddell H S., McDougall J. Does aspirin have a role in improving pregnancy outcome for women with the antiphospholipid syndrome? A randomized controlled trial. Am J Obstet Gynecol 2000 183 4 1008-1012
146. Triolo G, Ferrante A, Ciccia F et al. Randomized study of subcutaneous low molecular weight heparin plus aspirin versus intravenous immunoglobulin in the treatment of recurrent fetal loss associated with antiphospholipid antibodies. Arthritis Rheum 2003 48 3 728-731 (Pubitemid 36302009)
147. Goel N, Tuli A, Choudhry R. The role of aspirin versus aspirin and heparin in cases of recurrent abortions with raised anticardiolipin antibodies. Med Sci Monit 2006 12 3 CR132-CR136 (Pubitemid 43332264)
148. Laskin C A., Spitzer K A., Clark C A. et al. Low molecular weight heparin and aspirin for recurrent pregnancy loss: results from the randomized, controlled HepASA Trial. J Rheumatol 2009 36 2 279-287